Case Report | Open Access
Rathika Damodara Shenoy, Vijaya Shenoy, Vikram Shetty, "Chromosomal Abnormalities in Syndromic Orofacial Clefts: Report of Three Children", Case Reports in Genetics, vol. 2018, Article ID 1928918, 5 pages, 2018. https://doi.org/10.1155/2018/1928918
Chromosomal Abnormalities in Syndromic Orofacial Clefts: Report of Three Children
This case series of three children reports clinical features and chromosomal abnormalities seen in a craniofacial clinic. All presented with orofacial cleft, developmental or intellectual disability, and dysmorphism. Emanuel syndrome or supernumerary der (22)t(11; 22), the prototype of complex small supernumerary marker disorders, was seen in one child. Duplication 4q27q35.2 with concomitant deletion 21q22.2q22.3 and duplication 12p13.33p13.32 with concomitant deletion 18q22.3q23 seen in the remaining two children are not reported in literature. Maternal balanced translocation was established in both of these children.
Orofacial cleft (OFC) is a common congenital anomaly with a prevalence of 1 in 600 live-births. It includes cleft lip, cleft lip with palate (CLP), and cleft palate (CP). Chromosomal etiology accounts for 6% of all children with OFC . In birth cohort studies on clefts the most widely reported chromosomal disorders are trisomies 18 and 13 with poor survival beyond the age of one year [2–4]. Older children with cleft, developmental delay (DD), and minor dysmorphism are encountered in craniofacial clinics. Chromosomal etiology in these children may go unrecognized in infancy due to subtlety in presentation. Chromosomal microarray (CMA) is the first-line investigation of children with congenital anomalies, DD, and intellectual disability . Children with DD and craniofacial defects show significantly higher burden of genomic rearrangements than children with DD and autism or seizures . Array-based techniques have identified candidate chromosomal loci in children with CLP . This series describes the chromosomal abnormalities seen in three children who presented to our craniofacial clinic with DD and dysmorphism in addition to cleft.
Genomic DNA was extracted from whole blood treated with EDTA by standard protocol using protein precipitation solution (Qiagen, Germany). DNA concentration and purity were measured by biospectrometer (Eppendorf, Germany). Purified DNA was dissolved with nuclease free water and stored at −20°C until further processing. The CMA was performed with whole genome scanning panel (Illumina HumanCytoSNP-12 Beadchip, USA) according to manufacturer’s protocol utilizing 200 ng of DNA per sample in an accredited laboratory. This panel is incorporated with ~300,000 single nucleotide polymorphism probes with dose sensitivity of >800 genes. The resolution was 30kb for copy number variations and higher for regions of known cytogenetic importance. Data output was analyzed using GenomeStudio and KaryoStudio provided by the manufacturer.
Karyotype was performed on metaphase chromosomes obtained from peripheral lymphocytes and twenty Giemsa banded (450-500 level) spreads were studied. The International System for Human Cytogenetic Nomenclature was used for reporting . Snapshots to visualize the genomic rearrangements were done using University of California Santa Cruz (UCSC) browser human assembly GRCh37/hg19, February 2009 (http://genome.ucsc.edu/).
Parental consent for photography and diagnostics was obtained for all the children presented in this series upon approval by the study institute ethics committee.
3. Case Presentation
3.1. Proband 1
The infant, first born male, was seen at ten months of age with DD and seizures. There was no parental consanguinity. He had microcephaly and central hypotonia. Dysmorphism included unilateral ptosis, deep-set eyes, low set ears, CP, and micrognathia (Figure 1(a)). Magnetic resonance imaging (MRI) of the brain showed thinning of corpus callosum (Figure 1(b)). Karyotype showed marker chromosome (Figure 1(c)) and CMA partial trisomy of 11q and 22q characteristic of Emanuel syndrome (ES) . Mother had balanced translocation involving chromosomes 11 and 22 (Figure 1(d)).
3.2. Proband 2
This male child born of nonconsanguineous parentage presented with failure to thrive at four months of age. There was sibling death with congenital heart disease. He had microcephaly and spasticity. Dysmorphism included downward slant, prominent nose, ear anomalies, right CLP, retrognathia (Figure 2(a)), and rocker bottom feet. Atrial septal defect and patent ductus arteriosus were visualized on echocardiogram. Evaluation for renal anomalies revealed posterior urethral valve. MRI brain was normal. Karyotype showed derivative chromosome (Figure 2(b)) and CMA showed partial trisomy of 4q and partial monosomy of 21q. Mother had a balanced translocation involving chromosomes 4 and 21 (Figure 2(c)). Snapshots of microarray plots and coding genes in sequential order of dup 4q27q35.2 and del 21q22.2q22.3 regions are shown in Figures 2(d) and 2(e).
3.3. Proband 3
This 9-year-old boy born of nonconsanguineous parentage had intellectual disability with normal neurologic examination. He had hypertelorism, wide eyebrows, narrow nasal root, everted lower lip, short ears, short neck (Figure 3(a)), and operated scar of bilateral cleft lip with alveolus. MRI brain showed asymmetric lateral ventricle (Figure 3(b)). His CMA revealed partial trisomy of 12p and partial monosomy of 18q. Snapshots of microarray plots and coding genes in sequential order of dup 12p13.33p13.32 and del 18q22.3q23 are shown in Figures 3(c) and 3(d). Parental evaluation was normal.
Table 1 gives the molecular karyotype of these children with base pair location, size, number of genes involved, and the critical regions for phenotype correlation.
ES (Proband 1) is the prototype of complex and small supernumerary marker disorders. The most common non-Robertsonian rearrangement in humans is the translocation between chromosomes 11 and 22 as these chromosomes have palindromic AT repeats that are vulnerable to breaks and recombination during meiosis. ES results from 3:1 mal-segregation of usually the maternal balanced carrier state as in our case [9, 10]. The incidence of ES is not known. Features typical of ES were seen in Proband 1. CP is reported in 50% and hypoplastic corpus callosum in 20% among children with ES . However, preauricular pits noted in around 75% were not seen.
Partial trisomy 4q A is usually seen with autosomal monosomy; however, concomitant partial monosomy 21 is not reported in literature. Rinaldi et al.  describe a child with congenital heart defect, bilateral hydronephrosis, and partial trisomy of 4q24qter. Renal hypoplasia has been documented by others [13, 14]. Renal anomalies thus seem to be the major system involved in partial terminal 4q trisomy. CLP appears to be rare in this chromosomal abnormality . Developmental or intellectual disability is reported in genomic arrangements of either of the chromosomes 4q and 21q [15, 16]. The breakpoints described with partial monosomy 21q are variable and the phenotype described is mild [16, 17]. Therefore, the features seen in the proband were likely due to partial trisomy 4q.
Partial monosomy of 18q is associated with OFC with 18q22.3q23 as the critical region [18, 19]. Congenital aural atresia described with this partial monosomy was not seen in Proband 3. Partial trisomy of 12p13.3 occurring with partial monosomy 18q is not reported in literature. Parental evaluation was normal suggesting a de novo rearrangement. The wide eyebrows, everted lower lip, short neck, and intellectual disability were features of partial trisomy 12p [20, 21].
To conclude, this series compiles some of the rare and unreported chromosomal abnormalities that include duplication 4q27q35.2 with concomitant deletion 21q22.2q22.3 and duplication 12p13.33p13.32 with concomitant deletion 18q22.3q23. The report also substantiates 4q25q31.3 as a critical locus for renal anomaly and 18q22.3q23 for OFC. In a craniofacial clinic it may be important to identify subtle dysmorphism and DD to establish a chromosomal etiology.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- W. Maarse, A. M. Rozendaal, E. Pajkrt, C. Vermeij-Keers, A. B. M. van der Molen, and M.-J. H. van den Boogaard, “A systematic review of associated structural and chromosomal defects in oral clefts: When is prenatal genetic analysis indicated?” Journal of Medical Genetics, vol. 49, no. 8, pp. 490–498, 2012.
- E. Calzolari, A. Pierini, G. Astolfi et al., “Associated anomalies in multi-malformed infants with cleft lip and palate: an epidemiologic study of nearly 6 million births in 23 EUROCAT registries,” American Journal of Medical Genetics Part A, vol. 143, no. 6, pp. 528–537, 2007.
- M. Rittler, V. Cosentino, J. S. López-Camelo, J. C. Murray, G. Wehby, and E. E. Castilla, “Associated anomalies among infants with oral clefts at birth and during a 1-year follow-up,” American Journal of Medical Genetics Part A, vol. 155, no. 7, pp. 1588–1596, 2011.
- A. Sárközi, D. F. Wyszynski, and A. E. Czeizel, “Oral clefts with associated anomalies: Findings in the Hungarian Congenital Abnormality Registry,” BMC Oral Health, vol. 5, 2005.
- D. T. Miller, M. P. Adam, and S. Aradhya, “Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies,” Am J Hum Genet, vol. 86, no. 5, pp. 749–764, 2010.
- G. M. Cooper, B. P. Coe, S. Girirajan et al., “A copy number variation morbidity map of developmental delay,” Nature Genetics, vol. 43, no. 9, pp. 838–846, 2011.
- K. Osoegawa, G. M. Vessere, K. H. Utami et al., “Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation,” Journal of Medical Genetics, vol. 45, no. 2, pp. 81–86, 2008.
- A. Simons, L. G. Shaffer, and R. J. Hastings, “Cytogenetic nomenclature: changes in the ISCN 2013 compared to the 2009 edition,” Cytogenetic and Genome Research, vol. 141, no. 1, pp. 1–6, 2013.
- B. S. Emanuel and L. Medne, “Emanuel syndrome,” in GeneReviews®, M. P. Adam, H. H. Ardinger, and R. A. Pagon, Eds., Seattle (WA): University of Washington, Seattle, 2007, https://www.ncbi.nlm.nih.gov/books/NBK1263/.
- H. Kurahashi and B. S. Emanuel, “Long AT-rich palindromes and the constitutional t(11;22) breakpoint,” Human Molecular Genetics, vol. 10, no. 23, pp. 2605–2617, 2001.
- M. T. Carter, S. A. St. Pierre, E. H. Zackai, B. S. Emanuel, and K. M. Boycott, “Phenotypic delineation of Emanuel syndrome (supernumerary derivative 22 syndrome): Clinical features of 63 individuals,” American Journal of Medical Genetics Part A, vol. 149, no. 8, pp. 1712–1721, 2009.
- R. Rinaldi, C. De Bernardo, M. Assumma et al., “Cytogenetic and molecular characterization of a de novo 4q24qter duplication and correlation to the associated phenotype,” American Journal of Medical Genetics, vol. 118, no. 2, pp. 122–126, 2003.
- T. Otsuka, H. Fujinaka, M. Imamura, Y. Tanaka, H. Hayakawa, and S. Tomizawa, “Duplication of chromosome 4q: Renal pathology of two siblings,” American Journal of Medical Genetics, vol. 134, no. 3, pp. 330–333, 2005.
- M. Thapa, A. Asamoah, G. C. Gowans et al., “Molecular characterization of distal 4q duplication in two patients using oligonucleotide array-based comparative genomic hybridization (oaCGH) analysis,” American Journal of Medical Genetics Part A, vol. 164, no. 4, pp. 1069–1074, 2014.
- C. Lundin, L. Zech, K. Sjörs, C. Wadelius, and G. Annerén, “Trisomy 4q syndrome: Presentation of a new case and review of the literature,” Annales de Génétique, vol. 45, no. 2, pp. 53–57, 2002.
- E. D. O. Roberson, E. S. Wohler, J. E. Hoover-Fong et al., “Genomic analysis of partial 21q monosomies with variable phenotypes,” European Journal of Human Genetics, vol. 19, no. 2, pp. 235–238, 2011.
- R. Lyle, F. Béna, S. Gagos et al., “Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21,” European Journal of Human Genetics, vol. 17, no. 4, pp. 454–466, 2009.
- I. Feenstra, L. E. L. M. Vissers, M. Orsel et al., “Genotype-phenotype mapping of chromosome 18q deletions by high-resolution array CGH: an update of the phenotypic map,” American Journal of Medical Genetics Part A, vol. 143, no. 16, pp. 1858–1867, 2007.
- J. D. Eudy, D. L. Pickering, R. Lutz et al., “18q22.3 → 18q23 deletion syndrome and cleft palate,” American Journal of Medical Genetics Part A, vol. 152A, no. 4, pp. 1046–1048, 2010.
- L. Margari, M. L. Di Cosola, M. Buttiglione et al., “Molecular cytogenetic characterization and genotype/phenotype analysis in a patient with a de novo 8p23.2p23.3 deletion/12p13.31p13.33 duplication,” American Journal of Medical Genetics Part A, vol. 158, no. 7, pp. 1713–1718, 2012.
- R. Segel, I. Peter, L. A. Demmer, J. M. Cowan, J. D. Hoffman, and D. W. Bianchi, “The natural history of trisomy 12p,” American Journal of Medical Genetics Part A, vol. 140, no. 7, pp. 695–703, 2006.
Copyright © 2018 Rathika Damodara Shenoy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.